The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
HIV Diagnosis-Global Market Insights and Sales Trends 2024
Synopsis
HIV Diagnosis are used to detect the presence of the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), in serum, saliva, or urine. Such tests may detect antibodies, antigens, or RNA.
The global HIV Diagnosis market size is expected to reach US$ 5097 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of HIV Diagnosis in various end use industries. The expanding demands from the Diagnostic Laboratories, Hospitals, Blood Banks and Home Care Settings, are propelling HIV Diagnosis market. Antibody Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Viral Load Tests segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HIV Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HIV Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HIV Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HIV Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HIV Diagnosis covered in this report include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Thermo Fisher, Merck, Becton, Dickinson, Hologic and Abbott, etc.
The global HIV Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens Healthineers
Roche Diagnostics
Abbott Laboratories
Beckman Coulter
Thermo Fisher
Merck
Becton, Dickinson
Hologic
Abbott
Bio-Rad Laboratories
Global HIV Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HIV Diagnosis market, Segment by Type:
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Global HIV Diagnosis market, by Application
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HIV Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
HIV Diagnosis are used to detect the presence of the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), in serum, saliva, or urine. Such tests may detect antibodies, antigens, or RNA.
The global HIV Diagnosis market size is expected to reach US$ 5097 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of HIV Diagnosis in various end use industries. The expanding demands from the Diagnostic Laboratories, Hospitals, Blood Banks and Home Care Settings, are propelling HIV Diagnosis market. Antibody Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Viral Load Tests segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HIV Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HIV Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HIV Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HIV Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HIV Diagnosis covered in this report include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Thermo Fisher, Merck, Becton, Dickinson, Hologic and Abbott, etc.
The global HIV Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens Healthineers
Roche Diagnostics
Abbott Laboratories
Beckman Coulter
Thermo Fisher
Merck
Becton, Dickinson
Hologic
Abbott
Bio-Rad Laboratories
Global HIV Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HIV Diagnosis market, Segment by Type:
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Global HIV Diagnosis market, by Application
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HIV Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of HIV Diagnosis
1.1 HIV Diagnosis Market Overview
1.1.1 HIV Diagnosis Product Scope
1.1.2 HIV Diagnosis Market Status and Outlook
1.2 Global HIV Diagnosis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global HIV Diagnosis Market Size by Region (2018-2029)
1.4 Global HIV Diagnosis Historic Market Size by Region (2018-2023)
1.5 Global HIV Diagnosis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, HIV Diagnosis Market Size (2018-2029)
1.6.1 North America HIV Diagnosis Market Size (2018-2029)
1.6.2 Europe HIV Diagnosis Market Size (2018-2029)
1.6.3 Asia-Pacific HIV Diagnosis Market Size (2018-2029)
1.6.4 Latin America HIV Diagnosis Market Size (2018-2029)
1.6.5 Middle East & Africa HIV Diagnosis Market Size (2018-2029)
2 HIV Diagnosis Market by Type
2.1 Introduction
2.1.1 Antibody Tests
2.1.2 Viral Load Tests
2.1.3 CD4 Tests
2.1.4 Tests for Early Infant Diagnosis
2.1.5 Tests for Viral Identification
2.2 Global HIV Diagnosis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global HIV Diagnosis Historic Market Size by Type (2018-2023)
2.2.2 Global HIV Diagnosis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America HIV Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe HIV Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific HIV Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America HIV Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa HIV Diagnosis Revenue Breakdown by Type (2018-2029)
3 HIV Diagnosis Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic Laboratories
3.1.2 Hospitals
3.1.3 Blood Banks
3.1.4 Home Care Settings
3.1.5 Others
3.2 Global HIV Diagnosis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global HIV Diagnosis Historic Market Size by Application (2018-2023)
3.2.2 Global HIV Diagnosis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America HIV Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe HIV Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific HIV Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America HIV Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa HIV Diagnosis Revenue Breakdown by Application (2018-2029)
4 HIV Diagnosis Competition Analysis by Players
4.1 Global HIV Diagnosis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Diagnosis as of 2022)
4.3 Date of Key Players Enter into HIV Diagnosis Market
4.4 Global Top Players HIV Diagnosis Headquarters and Area Served
4.5 Key Players HIV Diagnosis Product Solution and Service
4.6 Competitive Status
4.6.1 HIV Diagnosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Siemens Healthineers
5.1.1 Siemens Healthineers Profile
5.1.2 Siemens Healthineers Main Business
5.1.3 Siemens Healthineers HIV Diagnosis Products, Services and Solutions
5.1.4 Siemens Healthineers HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.1.5 Siemens Healthineers Recent Developments
5.2 Roche Diagnostics
5.2.1 Roche Diagnostics Profile
5.2.2 Roche Diagnostics Main Business
5.2.3 Roche Diagnostics HIV Diagnosis Products, Services and Solutions
5.2.4 Roche Diagnostics HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Diagnostics Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories HIV Diagnosis Products, Services and Solutions
5.3.4 Abbott Laboratories HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.3.5 Beckman Coulter Recent Developments
5.4 Beckman Coulter
5.4.1 Beckman Coulter Profile
5.4.2 Beckman Coulter Main Business
5.4.3 Beckman Coulter HIV Diagnosis Products, Services and Solutions
5.4.4 Beckman Coulter HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.4.5 Beckman Coulter Recent Developments
5.5 Thermo Fisher
5.5.1 Thermo Fisher Profile
5.5.2 Thermo Fisher Main Business
5.5.3 Thermo Fisher HIV Diagnosis Products, Services and Solutions
5.5.4 Thermo Fisher HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck HIV Diagnosis Products, Services and Solutions
5.6.4 Merck HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Recent Developments
5.7 Becton, Dickinson
5.7.1 Becton, Dickinson Profile
5.7.2 Becton, Dickinson Main Business
5.7.3 Becton, Dickinson HIV Diagnosis Products, Services and Solutions
5.7.4 Becton, Dickinson HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.7.5 Becton, Dickinson Recent Developments
5.8 Hologic
5.8.1 Hologic Profile
5.8.2 Hologic Main Business
5.8.3 Hologic HIV Diagnosis Products, Services and Solutions
5.8.4 Hologic HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.8.5 Hologic Recent Developments
5.9 Abbott
5.9.1 Abbott Profile
5.9.2 Abbott Main Business
5.9.3 Abbott HIV Diagnosis Products, Services and Solutions
5.9.4 Abbott HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.9.5 Abbott Recent Developments
5.10 Bio-Rad Laboratories
5.10.1 Bio-Rad Laboratories Profile
5.10.2 Bio-Rad Laboratories Main Business
5.10.3 Bio-Rad Laboratories HIV Diagnosis Products, Services and Solutions
5.10.4 Bio-Rad Laboratories HIV Diagnosis Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Laboratories Recent Developments
6 North America
6.1 North America HIV Diagnosis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HIV Diagnosis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HIV Diagnosis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HIV Diagnosis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HIV Diagnosis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HIV Diagnosis Market Dynamics
11.1 HIV Diagnosis Industry Trends
11.2 HIV Diagnosis Market Drivers
11.3 HIV Diagnosis Market Challenges
11.4 HIV Diagnosis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
